How many chiral centers in Lovastatin

Support cholesterol lowering agents with micronutrients

Banach, M. et al. (2015): Statin therapy and plasma coenzyme Q10 concentrations - A systematic review and meta-analysis of placebo-controlled trials. Pharmacol Res 99: 329-36. https://www.ncbi.nlm.nih.gov/pubmed/26192349, accessed on: July 19, 2017.

Deutsches Ärzteblatt (2012): Side effect: Statins make muscles tired. Deutscher Ärzteverlag GmbH Berlin (accessed on: June 8, 2017) https://www.aerzteblatt.de/nachrichten/50574, accessed on: July 19, 2017.

du Souich, P. et al. (2017): Myotoxicity of statins: Mechanism of action. Pharmacol Ther. S0163-7258 (17) 30043-8. https://www.ncbi.nlm.nih.gov/pubmed/28223230, accessed on: July 19, 2017.

Failla, M.L. et al. (2014): Increased bioavailability of ubiquinol compared to that of ubiquinone is due to more efficient micellarization during digestion and greater GSH-dependent uptake and basolateral secretion by Caco-2 cells. J Agric Food Chem. 62 (29): 7174-82. https://www.ncbi.nlm.nih.gov/pubmed/24979483, accessed on: July 19, 2017.

Fedacko, J. et al. (2013): Coenzyme Q (10) and selenium in statin-associated myopathy treatment. Can J Physiol Pharmacol. 91 (2): 165-70. https://www.ncbi.nlm.nih.gov/pubmed/23458201, accessed on: July 19, 2017.

Gröber, U. (2018): Drugs and Micronutrients - Medication-Oriented Supplementation. 4th edition. Wissenschaftliche Verlagsgesellschaft Stuttgart.

Grober, U. et al. (2018): Important drug-micronutrient interactions: a selection for clinical practice. Crit Rev Food Sci Nutr. 2018 Dec 23: 1-19. https://www.ncbi.nlm.nih.gov/pubmed/30580552, accessed on: January 14, 2019.

Gröber, U. (2011): Micronutrients. Metabolic Tuning - Prevention - Therapy. 3rd edition. Wissenschaftliche Verlagsgesellschaft mbH Stuttgart.

Hosoe, K. et al. (2007): Study on safety and bioavailability of ubiquinol (Kaneka QH) after single and 4-week multiple oral administration to healthy volunteers. Regul Toxicol Pharmacol. 47 (1): 19-28. https://www.ncbi.nlm.nih.gov/pubmed/16919858, accessed on: July 19, 2017.

Michalska-Kasiczak, M. et al. (2015): Analysis of vitamin D levels in patients with and without statin-associated myalgia - a systematic review and meta-analysis of 7 studies with 2420 patients. Int J Cardiol. 178: 111-6. https://www.ncbi.nlm.nih.gov/pubmed/25464233, accessed on: July 19, 2017.

Pereda, C.A. & Nishishinya, M.B. (2016): Is there really a relationship between serum vitamin D (25OHD) levels and the musculoskeletal pain associated with statin intake? A systematic review. Reumatol Clin. 12 (6): 331-335. https://www.ncbi.nlm.nih.gov/pubmed/27133556, accessed on: July 19, 2017.

Perez-Castrillón JL et al. (2010): Vitamin d levels and lipid response to atorvastatin. Int J Endocrinol 320721. https://www.ncbi.nlm.nih.gov/pubmed/20016682, accessed on: July 19, 2017.

Qin, X.F. et al. (2015): Effects of vitamin D on plasma lipid profiles in statin-treated patients with hypercholesterolemia: A randomized placebo-controlled trial. Clin Nutr. 34 (2): 201-6. https://www.ncbi.nlm.nih.gov/pubmed/24844869, accessed on: July 19, 2017.

Skarlovnik, A. et al. (2014): Coenzyme Q10 supplementation decreases statin-related mild-to-moderate muscle symptoms: a randomized clinical study. Med Sci Monit. 20: 2183-8. https://www.ncbi.nlm.nih.gov/pubmed/25375075, accessed on: July 19, 2017.

Zlatohlavek, L. (2012): The effect of coenzyme Q10 in statin myopathy. Neuro Endocrinol Lett 33 Suppl 2: 98-101. https://www.ncbi.nlm.nih.gov/pubmed/23183519, accessed on: July 19, 2017.